Creating the 365 Day Long Conference and Expo 2014


Published on

The benefits of a year round event models are endless. Implementing a digital media platform with the right mix of technology, skilled personnel, consultants, vendors and “content” strategy prove extremely profitable. This approach enables the show organizer, attendees, exhibitors, sponsors, presenters and prospects to engage before, during and after a live event (including, education, operations, promotion, sales, content, data, social media, face-to-face).

Published in: Marketing
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Creating the 365 Day Long Conference and Expo 2014

  1. 1. Creating the 365 Day Long Conference and Expo March 10, 2014 3:15 PM– 4:30 PM Hashtag: #ideas14 LE3 Barbara A. Myers, CAE, Vice President, Association Services, IMN Solutions Kevin Miller, President, Frost Miller Group
  2. 2. Learner Outcomes • To learn benefits of a year round event model. • To develop a strategy for transitioning an event/exhibition to a year round experience. • To gain and share ideas for specific tactics that can be implemented.
  3. 3. What is a 365 Day Experience? • IAEE Future Trends Task Force – White Paper: Future Trends Impacting the Exhibition and Events Industry. • Transitioning ―episodic‖ events to year-round communities around specific content • Implementing a digital media platform with the right mix of technology, skilled personnel, consultants, vendors and ―content‖ strategy. • Enables the show organizer, attendees, exhibitors, sponsors, presenters and prospects to engage before, during and after a live event (including, education, operations, promotion, sales, content, data, social media, face-to-face)
  4. 4. Benefits • Counters impact of digital media’s 24/7 competitive interaction with fixed date F2F events • Increases engagement (among all event stakeholders which value/ROI) • Expands reach and generates impressions outside existing databases, lists, etc. • Financial (revenue generation/cost containment) • Addresses generation challenges and reaches ―online generation‖
  5. 5. ―The Next On-line Generation‖ How Tweens are Communicating!
  6. 6. By the Numbers…
  7. 7. Strategy and Planning Strategic Planning Goals Audience Assessment Marketing Execution Engagement Tactics
  8. 8. Strategy • Identify events to transition from ―episodic‖ to year-round communities aligned with strategic priorities and growth goals of the association • Evaluate current digital media strategy and use • Answer question - ―What kind of value should I be creating for my audience year-round that makes the event the natural next step in their buying process?‖
  9. 9. Goals • Engagement • Mission Fulfillment • Revenue
  10. 10. Audience Assessment Non- Attendees Exhibitor/Sponsors Members Speakers Press/Bloggers
  11. 11. Marketing • Clearly Defined Plan • Describe Target Audience • Tactics Align with Audience • Maximize Registration Opportunities • Use Social Media to Recruit, Engage, and Retain Audiences • Seek Ongoing, Persistent Relationships with Audience
  12. 12. Content in Action Page(1(of(3 From: Renee&Smith To: Barbara&Myers CC: Danielle&Hould Here’s&the&combined&email. Renee & From: ISPE [] Sent: Wednesday, September 11, 2013 7:46 AM To: Renee Smith Subject: ** iMIS Email Marketing Test ** Don't Miss ISPE's Upcoming Events Send to a friend | Mobile Version While ISPE finalizes programming for upcoming educational events, be sure to visit our conference websites for the latest updates on speakers, agendas and session details. The State of QbD in the BioPharmaceutical Industry: Criticality Assessment, Design Space Implementation and Control 10 - 11 April 2013 • San Francisco, California USA Can your company afford the cost of production without QbD? Quality by Design can significantly alter the risk landscape and produce significant business benefits. This groundbreaking event offers you in-depth case studies, lessons learned and best practices in implementing QbD. Explore challenges and solutions with experts and peers in workshops on design space, control strategies, successful dossiers and lifecycle management. Who is attending? Leaders from Abbott, Amgen, Eli Lilly, Page(2(of(3 Genentech, MedImmune, Merck, Pfizer and more! Early bird registration ends 12 March 2013. Add this conference to your calendar Redefining the "C" in CGMP: Ensuring a Reliable Supply of Quality Medicines 11 - 13 June 2013 • Baltimore, Maryland USA ISPE and FDA collaborate to provide content focused on creating and maintaining a quality culture. Special events include Breakfast with the Inspectors, Meet the Press and Hot Topic Discussion Forum. Delegates will also have the unique opportunity to be among the first to hear results of ISPE’s Drug Shortage Survey, which will be announced at the conference. Early bird registration ends 13 May 2013. Add this conference to your calendar Biotechnology 2013: Looking Ahead to the 4th Decade 27 - 28 August 2013 • Durham, North Carolina USA As the modern Biotechnology Industry moves into its fourth decade, the dynamics of the industry are changing on many different fronts. This 2-day educational intensive will provide focused content on: Biopharmaceutical manufacturing and process development Facility design and integration Compliance and process validation Early bird registration ends 30 July 2013. Add this conference to your calendar 14% Open Rate 23% Open Rate Page(1(of(2 To: Renee Smith Subject: ** iMIS Email Marketing Test ** Learn How the A-VAX Case Study Can Help You If this email does not display properly, click here to view the mobile version. What You Need to Know about the A-VAX Case Study Register today to learn practical applications directly from study participants Register Today >> Understand and take away practical applications from the A-VAX Case Study at Biotechnology, a 2-day Symposium 27 – 28 August 2013 in Durham, NC. Sam Venugopal, Director, PricewaterhouseCoopers and Bradley Kosiba, PhD, CPIP, Principal, BK Collaborative LLC will lead this important workshop where delegates will Biotechnology is brought to you by ISPE and the Biotech CoP in cooperation with your local CaSA Chapter! Explore the content and application of the A-VAX Case Study. Understand how QbD can be applied to vaccine development and benefit the manufacturing lifecycle. Identify the specific challenges involved in QbD and ways they can be overcome in the vaccine environment. Gain insight into the challenges regulators face as they better define their expectations related to QbD. Speakers from companies involved will participate Michael Washabaugh, PhD, Senior Director, MedImmune Paul Rohlfing, Senior Director Global CMC, Pfizer, Inc. Michael Schwartz, Associate Director Global Regulatory Affairs, GlaxoSmithKline-Vaccines Michael Kosinski, Senior Principle Scientist, Merck & Co, Inc. Take a quick, 3-question quiz about the A-VAXTake a quick, 3-question quiz about the A-VAX Case Study for a chance to win aCase Study for a chance to win a complimentarycomplimentary registration to this conferenceregistration to this conference.*.* Learn more at: *Registration includes conference fee only valued at ($1745-2,014). Winner is responsible for lodging and travel expenses. Contest only applicable to new registrants. Winner will be announced and contacted on 12 August 2013 © 2013 ISPE 60% Open Rate
  13. 13. Execution • Evaluate internal/external resources • Buy-in from organizational stakeholders • Roles and responsibilities • Strategy/goals, goal oriented tactical plan and time lines • Budget • Training • Evaluate against goals
  14. 14. Engagement Tactics Communication • Digital content and media: streaming and downloads • SEM advertising: banner and text • Microsites and similar event-branded websites – content hub! • Content sharing: Slideshare, iTunesU, YouTube • Email: both email marketing and updates/advisory • Twitter (or similar) as back channel during presentation Participation • Online/mobile gaming and sweepstakes • Mobile-specific applications such as attendee networking/notification • ―Virtual/Hybrid‖ events and content distribution (―remote‖ education, networking, etc.) • Physical interactive touchscreens, interactive environments • Augmented/reality,enhanced reality • Tablet-guided discussion — animations, imagery, diagrams • NFC, RFID — lead capture, measurement • Gamification • QR Codes — more info, check-in’s credential exchange Propagation • Blogs and similar one-to-many publishing platforms • -Twitter, Facebook, association propriety social networks and other one-to-one engagement platforms • #Hashtags • RSS and other content syndication
  15. 15. Questions?
  16. 16. Contact Us Barbara A. Myers, CAE Vice President, Association Services IMN Solutions Kevin Miller President Frost Miller Group